CAR: Clinical Trials

4 trials for CAR, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Unknown 4
Phase 21Unknown 1

Follow CAR: new trials by email Literature Review of CAR trials Research Report on CAR

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ThisCART19A for B-NHL Relapsed After Auto-CAR T
ThisCART19A with Dose Level 1, ThisCART19A with Dose Level 2 - CAR, B Cell Lymphoma
Phase 1UnknownThe First Affiliated Hospital of Soochow University202022-12-012023-01-19
ThisCART19A Bridging to alloHSCT for R/R B-ALL
Treatment - CAR, Refractory Acute Lymphoblastic Leukemia
Phase 1UnknownThe First Affiliated Hospital of Soochow University202022-12-012023-01-11
Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia
Phase I, Phase II - Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood
Phase 1 / Phase 2UnknownKK Women's and Children's Hospital482022-07-182023-03-09
ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.
CAR T-cell therapy - Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia
Phase 1UnknownNational University Hospital, Singapore402021-04-282021-09-09

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Lymphoma, B-Cell (1)  ·  Lymphoma, Non-Hodgkin (1)

Broader conditions

Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunoproliferative Disorders (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Hematologic Diseases (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphoma (1)

Interventions

Clinical Trials, Phase I as Topic (1)  ·  Clinical Trials, Phase II as Topic (1)  ·  Immunotherapy, Adoptive (1)  ·  Therapeutics (1)

Sponsors

The First Affiliated Hospital of Soochow University (2)  ·  KK Women's and Children's Hospital (1)  ·  National University Hospital, Singapore (1)

Countries

China (2)  ·  Singapore (2)

Top investigators

Allen Yeoh, M.D (1)  ·  Dario Campana, M.D, PhD (1)  ·  Michaela Seng, MD (1)  ·  Wing Hang Leung, MD PhD (1)